Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2010	FY 2009
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2010	Dec 31, 2009
Manufacture and Sale of Medicines				64.62B	70.93B	44.81B	41.43B	40.17B
Manufacture and Sale of Medicines Growth				-8.89%	58.31%	8.14%	3.14%	-23.39%
Total				64.62B	70.93B	44.81B	41.43B	40.17B
Total Growth				-8.89%	58.31%	8.14%	3.14%	-23.39%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2010	FY 2009
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2010	Dec 31, 2009
Republic of Korea				61.54B	67.65B	44.43B	41.12B	40.07B
Republic of Korea Growth				-9.02%	52.25%	8.04%	2.64%	-
Other				-	35.50M	10.37M	35.11M	-
Other Growth				-	242.31%	-70.46%	-	-
North America				195.29M	454.12M	59.20M	117.62M	70.53M
North America Growth				-57.00%	667.09%	-49.67%	66.77%	-
Asia				1.90B	2.31B	307.33M	155.57M	35.18M
Asia Growth				-17.49%	650.99%	97.55%	342.23%	-
Total				63.64B	70.44B	44.81B	41.43B	40.17B
Total Growth				-9.65%	57.22%	8.14%	3.14%	-

Source: S&P Global Market Intelligence.